1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
(
- Contribution to journal › Article
- 2020
-
Mark
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
(
- Contribution to journal › Article
- 2015
-
Mark
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis
(
- Contribution to journal › Article
- 2011
-
Mark
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
(
- Contribution to journal › Article